Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma
Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma
复制标题
基因LRFN2(rs2494938)和DNAH11(rs2285947)的内含子多态性是食管鳞状细胞癌的预后指标
DOI:
10.1186/s12881-019-0796-9
复制
发表时间:
2019-05
影响因子:
--
通讯作者:
Chen Xiaofei
中科院分区:
文献类型:
--
作者:
Wang Jiru;Wang Qiuzi;Wei Bin;Zhou Yu;Qian Zhaoye;Gao Yong;Chen Xiaofei
Background:Genome wide association study (GWAS) has become the major means to screen for the genetic variants associated with risk and prognosis of different diseases. A recent GWAS has discovered three novel intronic single nucleotide polymorphisms in genes LRFN2 (rs2494938), DNAH11 (rs2285947) and PLCXD2 (rs2399395) that are associated with altered risk of esophageal squamous cell carcinoma (ESCC) among Han Chinese populations. However, the prognostic significance of these variations in ESCC remains unclear.Methods:To investigate the association of three novel single nucleotide polymorphisms (rs2494938, rs2285947, rs2399395) with the prognosis of ESCC patients, we recruited 287 ESCC patients treated with surgical resection and evaluated the potential significance of the three polymorphisms through Kaplan-Meier survival analysis, log-rank test, and Cox proportional hazards regression models.Results:The ESCC patients carrying genotype AA at rs2494938 had worse survival and genotype GG at 2285947 had better prognosis (Log-rank P = 0.003 and Log-rank P = 0.037, respectively). In addition, rs2494938 at 6p21.1 was independently associated with overall survival of ESCC patients in recessive model [AA vs. GG/GA, HR = 3.12, 95% CI = 1.43-6.83, P = 0.004], rs2285947 at 7p15.3 was independently associated with overall survival of ESCC patients in both dominant model [AA/GA vs. GG, HR = 1.59, 95% CI = 1.02-2.49, P = 0.042] and additive model [AA vs. GA vs. GG, HR = 1.45, 95% CI = 1.05-2.01, P = 0.025].Conclusions:This study demonstrated that the polymorphisms rs2494938 at 6p21.1 and rs2285947 at 7p15.3 may serve as independent prognostic biomarkers for ESCC, implying the potential biological role of their related genes (LRFN2 and DNAH11) in the process of ESCC development.
登录
查看更多内容
DOI:
10.2147/cpaa.s90367
发表时间:
2015
期刊:
Clinical pharmacology : advances and applications
影响因子:
--
作者:
North WG;Liu F;Tian R;Abbasi H;Akerman B
通讯作者:
Akerman B
影响因子:
56.9
作者:
HAN, J;LEE, JD;ULEVITCH, RJ
通讯作者:
ULEVITCH, RJ
影响因子:
5.3
作者:
Wang, CY;Chang, K;Wenthold, RJ
通讯作者:
Wenthold, RJ
影响因子:
6.4
作者:
Liu, Jun-Wei;Kim, Myoung Sook;Sidransky, David
通讯作者:
Sidransky, David
影响因子:
3.5
作者:
Kang, Meiyun;Ding, Ojie;Zhang, Zhengdong
通讯作者:
Zhang, Zhengdong